Toronto - Delayed Quote CAD
Resverlogix Corp. (RVX.TO)
0.0400
+0.0050
+(14.29%)
At close: 1:01:40 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-3,886
-3,886
-2,512
-3,630
-8,024
Investing Cash Flow
-377
-377
-516
-473
-833
Financing Cash Flow
4,359
4,359
2,993
4,152
8,807
End Cash Position
99
99
5
40
6
Capital Expenditure
-472
-472
-448
-450
-877
Issuance of Capital Stock
--
--
278
4,609
4,017
Issuance of Debt
4,378
4,378
3,160
441
6,080
Repayment of Debt
--
--
-406
-994
-871
Free Cash Flow
-4,358
-4,358
-2,960
-4,080
-8,901
12/31/2021 - 5/7/2004
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ZHCLF Zenith Capital Corp.
0.0001
0.00%
TH.TO Theratechnologies Inc.
3.9100
+3.17%
137.SG Aldeyra Therapeutics Inc
2.3180
+8.47%
AGN.CN Algernon Pharmaceuticals Inc.
0.0800
0.00%
FENC Fennec Pharmaceuticals Inc.
5.69
+0.71%
ONC.TO Oncolytics Biotech Inc.
0.8100
-3.57%
MSCL.TO Satellos Bioscience Inc.
0.6600
+6.45%
RLF.SW Relief Therapeutics Holding SA
2.3550
-1.67%
PHAR Pharming Group N.V.
8.58
+1.42%
NUVL Nuvalent, Inc.
73.98
+1.75%